ClinicalTrials.gov
public full text
Public Domain
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
This clinical trial will explore the safety and effect of GCSF-mobilized autologous ex vivo selected CD34 cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single intracoronary infusion of CLBS16.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction#801660
- BFPET for Regional Myocardial Perfusion Imaging#859355
- Functional and Clinical Benefits of PCI in Patients With CTO#1173379
- Effect of Evolocumab on Coronary Endothelial Function#848662
- The Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in the Characterization of Ultra-Stable Voltage Sensitive Fluorophores#1106914
Record · ID 830960
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive